Apart from its metabolic duties, ERRγ also plays a cancer-promoting role in malignancies like small-cell lung cancer (SCLC), hepatocellular carcinoma (HCC), breast cancer, and retinoblastoma, aiding in resistance to therapy and survival under low-oxygen conditions [6–8]. Here, ESRRG is linked to hepatocellular carcinoma.